Preimplantation Genetic Testing Market
According to Intent Market Research, the Preimplantation Genetic Testing Market is expected to grow from USD 667 million in 2023 at a CAGR of 10.9% to touch USD 1,374 million by 2030. The preimplantation genetic testing market is dominated by key players such as Agilent, Thermo Fisher Scientific, Illumina, Revvity, Abbott, Takara Bio, Qiagen, MedGenome, and Berry Genomics.